Alcohol use disorder clinical trials

Explore recruiting alcohol use disorder clinical trials.

Recruiting alcohol use disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alcohol use disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Psilocybin in alcohol use disorder with comorbid depression - Randomized double-blind controlled pilot study.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 1, open-label, cross-over study in healthy volunteers to assess the pharmacokinetic profile of Prazosin and Cyproheptadine following single dose oral administration of KT110 tablet and following administration of Alpress and Periactine marketed tablets

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Does the Glucagon-like Peptide 1 (GLP-1) receptor agonist semaglutide reduce alcohol intake in patients with Alcohol Use Disorder and comorbid obesity?

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Two-part, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption (Part A) and Alcohol Craving (Part B) in Subjects Diagnosed with Moderate to Severe Alcohol Use Disorder and Seeking Treatment

Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Alcohol use disorder trials by city

Alcohol use disorder in Toronto Alcohol use disorder in Vancouver Alcohol use disorder in Montreal Alcohol use disorder in Calgary Alcohol use disorder in Edmonton Alcohol use disorder in Ottawa Alcohol use disorder in Winnipeg Alcohol use disorder in Quebec City Alcohol use disorder in Hamilton Alcohol use disorder in Kitchener Alcohol use disorder in London Alcohol use disorder in Halifax Alcohol use disorder in New York Alcohol use disorder in Los Angeles Alcohol use disorder in Chicago Alcohol use disorder in Houston

Other conditions

Restless legs syndrome Essential tremor Dementia Depression Anxiety Bipolar disorder Schizophrenia PTSD OCD ADHD Insomnia Postpartum depression Substance use disorder COPD Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Chronic cough Crohn's disease Ulcerative colitis Irritable bowel syndrome Celiac disease